| The WISDOM team uses grid-powered software to screen for potential drug-leads, searching for small molecules called ligands that can bind to and disable disease-promoting proteins. The image shows a simulated docked compound (green) that inhibits alpha amylase (an enzyme) as a means of treating diabetes. Image courtesy of Jean Salzemann | Quantity, quality . . . commodity? “This successful test with WISDOM shows that applications within EGEE can run well on Digital Ribbon resources,” says Jones. “Now we can see if other user communities might benefit.” Data used for the test consisted of 750 chemical dockings—potential candidates for diabetes drugs. In about 12 hours they ran calculations corresponding to 55 days on a single processing unit. “While this was small for us in comparison to previous sets of calculations,” says Jean Salzemann, computing researcher with the WISDOM collaboration, “it tested new ways of sending jobs. When we are preparing future data challenges, we could consider splitting the data load between EGEE and Digital Ribbon resources.” In their last data challenge, WISDOM tested 4 million potential drug candidates using 5,000 processing cores. With these they were able to run in two months what it would have taken a single CPU four centuries to complete. If they had 10,000 cores, they could have done the calculations in one month. “We test millions of potential drugs in our data challenges,” says Salzemann, “ideally we would have access to one core per potential drug or ‘ligand.’ With this we would have the complete results in about an hour.” —Danielle Venton, EGEE Digital Ribbon's service registry covers a multitude of platforms, processors, architectures, offering resources to public and private organizations. More information about using gLite in business environments is available online. |